Triptan overuse in migraine in primary care, a proactive approach
- Conditions
- migraine10019231
- Registration Number
- NL-OMON30289
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
1. registered in Electronic Patient Register of the GP
2. prescriptions for triptans, dosed 24 doses or more per year (or 6 or more daily doses in the last 6 months)
Exclusion Criteria
younger than 18 years old
cognitive impairment
psychiatric illness
end-stage of a malignant disease
non-Dutch speaking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Reduction of score on the HIT-6 questionnaire (measuring headache impact) at<br /><br>six months after the start of the intervention. </p><br>
- Secondary Outcome Measures
Name Time Method <p>HIT-6 questionnaire at 3 and 12 months follow up<br /><br>*migraine frequency (diary over 1 month as used in Dutch General Practice, to<br /><br>be filled in at baseline and follow up moments)<br /><br>*quality of life (questionnaires: visual analogue scale and societal EQ-5D)<br /><br>*triptan/analgesic use (information from prescriptions registered in EPR)<br /><br>*prophylactic medication (information from prescriptions registered in EPR)</p><br>